51477-10-2 Usage
Description
(E)-1-(4-bromophenyl)-3-(4-methylphenyl)prop-2-en-1-one is a chalcone derivative with a molecular formula C15H11BrO. It is a yellow solid with a melting point of around 94-97°C. (E)-1-(4-bromophenyl)-3-(4-methylphenyl)prop-2-en-1-one has potential biological activities and is being studied in the field of medicinal chemistry for its potential as a drug candidate. (E)-1-(4-bromophenyl)-3-(4-methylphenyl)prop-2-en-1-one's structure contains a conjugated system with a keto group, making it a candidate for synthetic anti-tumor and anti-inflammatory agents. Its chemical properties and potential biological activities make it an interesting subject for further research and development.
Uses
Used in Pharmaceutical Industry:
(E)-1-(4-bromophenyl)-3-(4-methylphenyl)prop-2-en-1-one is used as a potential drug candidate for its potential anti-tumor and anti-inflammatory properties. (E)-1-(4-bromophenyl)-3-(4-methylphenyl)prop-2-en-1-one's conjugated system with a keto group makes it a promising candidate for the development of synthetic agents in the pharmaceutical industry.
Used in Medicinal Chemistry Research:
(E)-1-(4-bromophenyl)-3-(4-methylphenyl)prop-2-en-1-one is used as a subject of study in medicinal chemistry to explore its potential biological activities and its application as a drug candidate. (E)-1-(4-bromophenyl)-3-(4-methylphenyl)prop-2-en-1-one's unique structure and properties make it an interesting area of research for the development of new therapeutic agents.
Used in Chemical Synthesis:
(E)-1-(4-bromophenyl)-3-(4-methylphenyl)prop-2-en-1-one is used as a starting material or intermediate in the synthesis of various chemical compounds, particularly those with potential applications in the pharmaceutical and medicinal chemistry fields. Its unique structure and reactivity make it a valuable component in the development of new synthetic pathways and products.
Check Digit Verification of cas no
The CAS Registry Mumber 51477-10-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,4,7 and 7 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 51477-10:
(7*5)+(6*1)+(5*4)+(4*7)+(3*7)+(2*1)+(1*0)=112
112 % 10 = 2
So 51477-10-2 is a valid CAS Registry Number.
InChI:InChI=1/C16H13BrO/c1-12-2-4-13(5-3-12)6-11-16(18)14-7-9-15(17)10-8-14/h2-11H,1H3/b11-6+
51477-10-2Relevant articles and documents
Efficient base-free asymmetric one-pot synthesis of spiro[indoline-3,3′-pyrrolizin]-2-one derivatives catalyzed by chiral organocatalyst
Chithiraikumar, Chinnadurai,Ponmuthu, Kottala Vijaya,Harikrishnan, Muniyasamy,Malini, Nelson,Sepperumal, Murugesan,Siva, Ayyanar
, p. 895 - 909 (2020/10/29)
A 1,3-dipolar cycloaddition reaction has been performed under organocatalytic conditions with high enantioselectivity by the utilization of bipyridine-based chiral quaternary ammonium bromide as an organocatalyst. Here, the reaction of 1,3-dipolar cycloaddition of azomethine ylide generated in situ from the decarboxylative condensation of α-amino acids and non-enolizable 1,2-diketones to the above dipolarophiles takes place.
Fabrication of Copper-based Silica-coated Magnetic Nanocatalyst for Efficient One-pot Synthesis of Chalcones via A3 Coupling of Aldehydes-Alkynes-Amines
Yadav, Priya,Yadav, Manavi,Gaur, Rashmi,Gupta, Radhika,Arora, Gunjan,Rana, Pooja,Srivastava, Anju,Sharma, Rakesh K.
, p. 2488 - 2496 (2020/03/26)
In the present work, we have synthesized bioactive and pharmacologically important chalcone motifs by employing green and efficient silica-coated magnetically separable catalyst, Cu@DBM@ASMNPs. The highly proficient nanocatalyst proves its invincibility f
Design, synthesis, and biological evaluation of novel thienopyrimidine derivatives as PI3Kα inhibitors
Yu, Lide,Wang, Qinqin,Wang, Caolin,Zhang, Binliang,Yang, Zunhua,Fang, Yuanying,Zhu, Wufu,Zheng, Pengwu
, (2019/10/02)
Three series of novel thienopyrimidine derivatives 9a-l, 15a-l, and 18a-h were designed and synthesized, and their IC50 values against four cancer cell lines HepG-2, A549, PC-3, and MCF-7 were evaluated. Most compounds show moderate cytotoxicity against the tested cancer cell lines. The most promising compound 9a showed moderate activity with IC50 values of 12.32 ± 0.96, 11.30 ± 1.19, 14.69 ± 1.32, and 9.80 ± 0.93 μM, respectively. The inhibitory activities of compounds 9a and 15a against PI3Kα and mTOR kinase were further evaluated. Compound 9a exhibited PI3Kα kinase inhibitory activity with IC50 of 9.47 ± 0.63 μM. In addition, docking studies of compounds 9a and 15a were also investigated.